Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 476

1.

Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).

Carmicheal J, Patel A, Dalal V, Atri P, Dhaliwal AS, Wittel UA, Malafa MP, Talmon G, Swanson BJ, Singh S, Jain M, Kaur S, Batra SK.

Biochim Biophys Acta Rev Cancer. 2019 Oct 30;1873(1):188318. doi: 10.1016/j.bbcan.2019.188318. [Epub ahead of print] Review.

PMID:
31676330
2.

A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study.

Ernani V, Jahan R, Smith LM, Marr AS, Kimbrough SE, Kos ME, Tijerina J, Pivovar S, Lakshmanan I, Ketcham M, Rauth S, Mallya K, Nasser MW, Jain M, Kessinger A, Batra SK, Ganti AK.

Cancer Treat Res Commun. 2019 Oct 7;22:100162. doi: 10.1016/j.ctarc.2019.100162. [Epub ahead of print]

3.

PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells.

Hein AL, Brandquist ND, Ouellette CY, Seshacharyulu P, Enke CA, Ouellette MM, Batra SK, Yan Y.

Oncogenesis. 2019 Oct 28;8(11):63. doi: 10.1038/s41389-019-0172-9.

4.

Uncovering and characterizing splice variants associated with survival in lung cancer patients.

West S, Kumar S, Batra SK, Ali H, Ghersi D.

PLoS Comput Biol. 2019 Oct 25;15(10):e1007469. doi: 10.1371/journal.pcbi.1007469. eCollection 2019 Oct.

5.

Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells.

Mirzapoiazova T, Li H, Nathan A, Srivstava S, Nasser MW, Lennon F, Armstrong B, Mambetsariev I, Chu PG, Achuthan S, Batra SK, Kulkarni P, Salgia R.

J Clin Med. 2019 Oct 18;8(10). pii: E1723. doi: 10.3390/jcm8101723.

6.

Radiomics in stratification of pancreatic cystic lesions: Machine learning in action.

Dalal V, Carmicheal J, Dhaliwal A, Jain M, Kaur S, Batra SK.

Cancer Lett. 2019 Oct 17. pii: S0304-3835(19)30520-8. doi: 10.1016/j.canlet.2019.10.023. [Epub ahead of print]

PMID:
31629933
7.

PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer.

Parte S, Virant-Klun I, Patankar M, Batra SK, Straughn A, Kakar SS.

Stem Cell Rev Rep. 2019 Sep 3. doi: 10.1007/s12015-019-09911-5. [Epub ahead of print]

PMID:
31482269
8.

Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation.

Gurumurthy CB, O'Brien AR, Quadros RM, Adams J Jr, Alcaide P, Ayabe S, Ballard J, Batra SK, Beauchamp MC, Becker KA, Bernas G, Brough D, Carrillo-Salinas F, Chan W, Chen H, Dawson R, DeMambro V, D'Hont J, Dibb KM, Eudy JD, Gan L, Gao J, Gonzales A, Guntur AR, Guo H, Harms DW, Harrington A, Hentges KE, Humphreys N, Imai S, Ishii H, Iwama M, Jonasch E, Karolak M, Keavney B, Khin NC, Konno M, Kotani Y, Kunihiro Y, Lakshmanan I, Larochelle C, Lawrence CB, Li L, Lindner V, Liu XD, Lopez-Castejon G, Loudon A, Lowe J, Jerome-Majewska LA, Matsusaka T, Miura H, Miyasaka Y, Morpurgo B, Motyl K, Nabeshima YI, Nakade K, Nakashiba T, Nakashima K, Obata Y, Ogiwara S, Ouellet M, Oxburgh L, Piltz S, Pinz I, Ponnusamy MP, Ray D, Redder RJ, Rosen CJ, Ross N, Ruhe MT, Ryzhova L, Salvador AM, Alam SS, Sedlacek R, Sharma K, Smith C, Staes K, Starrs L, Sugiyama F, Takahashi S, Tanaka T, Trafford AW, Uno Y, Vanhoutte L, Vanrockeghem F, Willis BJ, Wright CS, Yamauchi Y, Yi X, Yoshimi K, Zhang X, Zhang Y, Ohtsuka M, Das S, Garry DJ, Hochepied T, Thomas P, Parker-Thornburg J, Adamson AD, Yoshiki A, Schmouth JF, Golovko A, Thompson WR, Lloyd KCK, Wood JA, Cowan M, Mashimo T, Mizuno S, Zhu H, Kasparek P, Liaw L, Miano JM, Burgio G.

Genome Biol. 2019 Aug 26;20(1):171. doi: 10.1186/s13059-019-1776-2.

9.

Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIPs.

Francois RA, Zhang A, Husain K, Wang C, Hutchinson S, Kongnyuy M, Batra SK, Coppola D, Sebti SM, Malafa MP.

Cancer Cell Int. 2019 Jul 22;19:189. doi: 10.1186/s12935-019-0876-0. eCollection 2019.

10.

Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy.

Zhang W, Fan W, Rachagani S, Zhou Z, Lele SM, Batra SK, Garrison JC.

Sci Rep. 2019 Jul 31;9(1):11117. doi: 10.1038/s41598-019-47308-z.

11.

Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology.

Mambetsariev I, Mirzapoiazova T, Lennon F, Jolly MK, Li H, Nasser MW, Vora L, Kulkarni P, Batra SK, Salgia R.

J Clin Med. 2019 Jul 16;8(7). pii: E1038. doi: 10.3390/jcm8071038.

12.

Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells.

Banerjee K, Gautam SK, Kshirsagar P, Ross KA, Spagnol G, Sorgen P, Wannemuehler MJ, Narasimhan B, Solheim JC, Kumar S, Batra SK, Jain M.

Genes Cancer. 2019 May;10(3-4):52-62. doi: 10.18632/genesandcancer.189.

13.

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.

Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N.

J Exp Clin Cancer Res. 2019 Jun 18;38(1):266. doi: 10.1186/s13046-019-1264-2.

14.

Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.

Hollandsworth HM, Lwin TM, Amirfakhri S, Filemoni F, Batra SK, Hoffman RM, Dhawan P, Bouvet M.

J Surg Res. 2019 Oct;242:145-150. doi: 10.1016/j.jss.2019.04.048. Epub 2019 May 9.

PMID:
31077946
15.

Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer.

Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, Grandgenett PM, Kaur S, Batra SK.

EBioMedicine. 2019 Apr;42:375-385. doi: 10.1016/j.ebiom.2019.03.056. Epub 2019 Apr 5.

16.

FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.

Seshacharyulu P, Rachagani S, Muniyan S, Siddiqui JA, Cruz E, Sharma S, Krishnan R, Killips BJ, Sheinin Y, Lele SM, Smith LM, Talmon GA, Ponnusamy MP, Datta K, Batra SK.

Oncogene. 2019 Jun;38(26):5265-5280. doi: 10.1038/s41388-019-0791-9. Epub 2019 Mar 26.

17.

Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma.

Hall BR, Cannon A, Thompson C, Santhamma B, Chavez-Riveros A, Bhatia R, Nair HB, Nickisch K, Batra SK, Kumar S.

Genes Cancer. 2019 Feb;10(1-2):1-10. doi: 10.18632/genesandcancer.184.

18.

Aerodigestive Approach to Chronic Cough in Children.

Naime S, Batra SK, Fiorillo C, Collins ME, Gatti M, Krakovsky GM, Sehgal S, Bauman NM, Pillai DK.

Curr Treat Options Pediatr. 2018 Dec;4(4):467-479. doi: 10.1007/s40746-018-0145-9. Epub 2018 Nov 16.

PMID:
30859056
19.

Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer.

Lei F, Xi X, Batra SK, Bronich TK.

J Pharmacol Exp Ther. 2019 Sep;370(3):682-694. doi: 10.1124/jpet.118.255786. Epub 2019 Feb 22.

PMID:
30796131
20.

Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis.

Khatri I, Ganguly K, Sharma S, Carmicheal J, Kaur S, Batra SK, Bhasin MK.

Sci Rep. 2019 Jan 15;9(1):123. doi: 10.1038/s41598-018-36328-w.

21.

Cancer-associated mucins: role in immune modulation and metastasis.

Bhatia R, Gautam SK, Cannon A, Thompson C, Hall BR, Aithal A, Banerjee K, Jain M, Solheim JC, Kumar S, Batra SK.

Cancer Metastasis Rev. 2019 Jun;38(1-2):223-236. doi: 10.1007/s10555-018-09775-0. Review.

PMID:
30618016
22.

Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity.

Chaudhary S, Ganguly K, Muniyan S, Pothuraju R, Sayed Z, Jones DT, Batra SK, Macha MA.

J Natl Cancer Inst. 2019 Mar 1;111(3):233-244. doi: 10.1093/jnci/djy207.

PMID:
30615137
23.

Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer.

Uz M, Kalaga M, Pothuraju R, Ju J, Junker WM, Batra SK, Mallapragada S, Rachagani S.

J Control Release. 2019 Jan 28;294:237-246. doi: 10.1016/j.jconrel.2018.12.031. Epub 2018 Dec 18.

PMID:
30576747
24.

Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.

Pothuraju R, Rachagani S, Junker WM, Chaudhary S, Saraswathi V, Kaur S, Batra SK.

J Exp Clin Cancer Res. 2018 Dec 19;37(1):319. doi: 10.1186/s13046-018-0963-4. Review.

25.

Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic cancer.

Carmicheal J, Hayashi C, Huang X, Liu L, Lu Y, Krasnoslobodtsev A, Lushnikov A, Kshirsagar PG, Patel A, Jain M, Lyubchenko YL, Lu Y, Batra SK, Kaur S.

Nanomedicine. 2019 Feb;16:88-96. doi: 10.1016/j.nano.2018.11.008. Epub 2018 Dec 11.

PMID:
30550805
26.

Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells.

Vengoji R, Ponnusamy MP, Rachagani S, Mahapatra S, Batra SK, Shonka N, Macha MA.

Carcinogenesis. 2019 Mar 12;40(1):2-14. doi: 10.1093/carcin/bgy171. Review.

PMID:
30475990
27.

Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.

Barkeer S, Chugh S, Karmakar S, Kaushik G, Rauth S, Rachagani S, Batra SK, Ponnusamy MP.

BMC Cancer. 2018 Nov 22;18(1):1157. doi: 10.1186/s12885-018-5074-2.

28.

Unraveling the journey of cancer stem cells from origin to metastasis.

Nimmakayala RK, Batra SK, Ponnusamy MP.

Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):50-63. doi: 10.1016/j.bbcan.2018.10.006. Epub 2018 Nov 9. Review.

PMID:
30419314
29.

Hunting for transcription factors: STAT3 decoy in non-small cell lung cancer.

Carmicheal J, Kaur S, Batra SK, Ganti AK.

Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S254-S257. doi: 10.21037/tlcr.2018.09.06. No abstract available.

30.

Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma.

Wang J, Mirzapoiazova T, Carol Tan YH, Pang KM, Pozhitkov A, Wang Y, Wang Y, Mambetsariev B, Wang E, Nasser MW, Batra SK, Raz D, Reckamp K, Kulkarni P, Zheng Y, Salgia R.

Cancer Biol Ther. 2018;19(11):1023-1032. doi: 10.1080/15384047.2018.1472193. Epub 2018 Oct 12.

31.

A Comparative Analysis of Survival and Funding Discrepancies in Cancers with High Mortality.

Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Kumar S, Batra SK, Wang H, Ganti AK, Sasson AR, Are C.

Ann Surg. 2018 Sep 4. doi: 10.1097/SLA.0000000000003042. [Epub ahead of print]

PMID:
30188400
32.

Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors.

Parte SC, Batra SK, Kakar SS.

J Ovarian Res. 2018 Aug 18;11(1):69. doi: 10.1186/s13048-018-0439-3.

33.

Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions.

Roy S, Bag AK, Dutta S, Polavaram NS, Islam R, Schellenburg S, Banwait J, Guda C, Ran S, Hollingsworth MA, Singh RK, Talmadge JE, Muders MH, Batra SK, Datta K.

Cancer Res. 2018 Oct 1;78(19):5600-5617. doi: 10.1158/0008-5472.CAN-18-0562. Epub 2018 Aug 15.

34.

Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential.

Cannon A, Thompson C, Hall BR, Jain M, Kumar S, Batra SK.

Genes Cancer. 2018 Mar;9(3-4):78-86. doi: 10.18632/genesandcancer.171. Review.

35.

Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.

Chugh S, Barkeer S, Rachagani S, Nimmakayala RK, Perumal N, Pothuraju R, Atri P, Mahapatra S, Thapa I, Talmon GA, Smith LM, Yu X, Neelamegham S, Fu J, Xia L, Ponnusamy MP, Batra SK.

Gastroenterology. 2018 Nov;155(5):1608-1624. doi: 10.1053/j.gastro.2018.08.007. Epub 2018 Aug 4.

36.

MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling.

Uppada SB, Gowrikumar S, Ahmad R, Kumar B, Szeglin B, Chen X, Smith JJ, Batra SK, Singh AB, Dhawan P.

Mol Cancer. 2018 Aug 1;17(1):111. doi: 10.1186/s12943-018-0848-3.

37.

Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis.

Barkeer S, Chugh S, Batra SK, Ponnusamy MP.

Neoplasia. 2018 Aug;20(8):813-825. doi: 10.1016/j.neo.2018.06.001. Epub 2018 Jul 6. Review.

38.

MUC16 as a novel target for cancer therapy.

Aithal A, Rauth S, Kshirsagar P, Shah A, Lakshmanan I, Junker WM, Jain M, Ponnusamy MP, Batra SK.

Expert Opin Ther Targets. 2018 Aug;22(8):675-686. doi: 10.1080/14728222.2018.1498845. Epub 2018 Jul 26. Review.

39.

Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1.

Nimmakayala RK, Seshacharyulu P, Lakshmanan I, Rachagani S, Chugh S, Karmakar S, Rauth S, Vengoji R, Atri P, Talmon GA, Lele SM, Smith LM, Thapa I, Bastola D, Ouellette MM, Batra SK, Ponnusamy MP.

Gastroenterology. 2018 Sep;155(3):892-908.e6. doi: 10.1053/j.gastro.2018.05.041. Epub 2018 Jun 2.

40.

Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway.

Jahan R, Macha MA, Rachagani S, Das S, Smith LM, Kaur S, Batra SK.

Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2538-2549. doi: 10.1016/j.bbadis.2018.05.008. Epub 2018 May 16.

41.

Natural products: a hope for glioblastoma patients.

Vengoji R, Macha MA, Batra SK, Shonka NA.

Oncotarget. 2018 Apr 24;9(31):22194-22219. doi: 10.18632/oncotarget.25175. eCollection 2018 Apr 24. Review.

42.

Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models.

Kaushik G, Ponnusamy MP, Batra SK.

Stem Cells. 2018 Sep;36(9):1329-1340. doi: 10.1002/stem.2852. Epub 2018 Jul 29. Review.

43.

Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years.

Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Ganti AK, Are C, Sasson AR, Kumar S, Batra SK.

Oncotarget. 2018 Apr 10;9(27):19396-19405. doi: 10.18632/oncotarget.25036. eCollection 2018 Apr 10.

44.

Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.

Aithal A, Junker WM, Kshirsagar P, Das S, Kaur S, Orzechowski C, Gautam SK, Jahan R, Sheinin YM, Lakshmanan I, Ponnusamy MP, Batra SK, Jain M.

PLoS One. 2018 Apr 30;13(4):e0193907. doi: 10.1371/journal.pone.0193907. eCollection 2018.

45.

Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.

Mohapatra SS, Batra SK, Bharadwaj S, Bouvet M, Cosman B, Goel A, Jogunoori W, Kelley MJ, Mishra L, Mishra B, Mohapatra S, Patel B, Pisegna JR, Raufman JP, Rao S, Roy H, Scheuner M, Singh S, Vidyarthi G, White J.

Dig Dis Sci. 2018 May;63(5):1123-1138. doi: 10.1007/s10620-018-5000-0. Epub 2018 Mar 23. Review.

46.

Intracellular amyloid beta expression leads to dysregulation of the mitogen-activated protein kinase and bone morphogenetic protein-2 signaling axis.

Cruz E, Kumar S, Yuan L, Arikkath J, Batra SK.

PLoS One. 2018 Feb 22;13(2):e0191696. doi: 10.1371/journal.pone.0191696. eCollection 2018.

47.

Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis.

Saxena S, Hayashi Y, Wu L, Awaji M, Atri P, Varney ML, Purohit A, Rachagani S, Batra SK, Singh RK.

Oncotarget. 2017 Dec 23;9(5):5931-5943. doi: 10.18632/oncotarget.23644. eCollection 2018 Jan 19.

48.

p66Shc regulates migration of castration-resistant prostate cancer cells.

Ingersoll MA, Chou YW, Lin JS, Yuan TC, Miller DR, Xie Y, Tu Y, Oberley-Deegan RE, Batra SK, Lin MF.

Cell Signal. 2018 Jun;46:1-14. doi: 10.1016/j.cellsig.2018.02.008. Epub 2018 Feb 17.

49.

Emerging therapeutic potential of graviola and its constituents in cancers.

Qazi AK, Siddiqui JA, Jahan R, Chaudhary S, Walker LA, Sayed Z, Jones DT, Batra SK, Macha MA.

Carcinogenesis. 2018 Apr 5;39(4):522-533. doi: 10.1093/carcin/bgy024. Review.

50.

Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view.

Krishn SR, Ganguly K, Kaur S, Batra SK.

Carcinogenesis. 2018 May 3;39(5):633-651. doi: 10.1093/carcin/bgy019. Review.

Supplemental Content

Loading ...
Support Center